Bio Protocol vs Tria — how do they compare? Bio Protocol trades at Rp432.45 (market cap Rp982,16M, Rp150,34M 24h volume), while Tria trades at Rp151.47 (market cap Rp326,37M, Rp36,55M 24h volume). The key difference: Bio Protocol is far larger — about 3× Tria's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 2,2B / 10B TRIA (22%) for Tria. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Tria for 4 Days on average.
| BIO | TRIA | |
|---|---|---|
Market Cap | Rp982,16M | Rp326,37M |
Volume (24h) | Rp150,34M | Rp36,55M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 2,2B / 10B TRIA (22%) |
Typical Hold Time | 18 Days | 4 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
TRIA is trading at Rp150.352 with a market cap of Rp323.76M and a neutral technical signal. The token shows balanced momentum with RSI and ADX indicators in neutral to slightly positive zones, while support and resistance levels indicate a tight trading range. With only 22% of the max supply in circulation and a short average hold time of 4 days, liquidity and volatility are key considerations. No major protocol updates or ecosystem news were identified recently.
Overall outlook is neutral with potential for short-term range-bound trading. Key opportunities include low float dynamics if demand increases, but risks are high due to low liquidity, regulatory uncertainty in crypto markets, and minimal fundamental developments. Investors should monitor exchange volume and on-chain activity for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Tria is a self-custodial crypto neobank and cross-chain routing engine that enables seamless spending, trading, and earning within one application. It addresses blockchain fragmentation through its BestPath routing technology, enabling gasless, bridge-free transactions and card payments directly from user-controlled wallets. The TRIA token supports rewards, ecosystem access, and governance participation.
Read more on TRIA →